Name: Latest research reports of Abbott India Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: Axis Direct

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

31101.8500 29.55 (0.10%)

NSE Mar 25, 2025 15:31 PM

Near 52W High of ₹31898.95

Volume: 7,172

Abbott India Ltd.

02 Feb 2024

31101.85

0.10%

Result Update:Abbott India

Buy: Abbott India Ltd.

Recommendation Target

Axis Direct

Abbott India is growing 1.6 to 1.8 times faster than IPM, based on high brand recognition and an excellent product portfolio.Recommendation: BUY.

Abbott India Ltd. has an average target of 31900.00 from 3 brokers.